bioMerieux has acquired 21 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.
bioMerieux’s largest acquisition to date was in 2014, when it acquired BioFire Diagnostics for $450M. bioMerieux has acquired in 7 different US states, and 8 countries. The Company’s most targeted sectors include life science (53%) and medical products (43%).
Join Mergr and gain access to bioMerieux’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity21
- M&A Buy Activity21
- Total Sectors Invested 3
- Total Countries Invested 8
- M&A Buy/Sell Connections 4
- M&A Advisors 1